Cardiology

Prasugrel and ticagrelor: Equally safe and effective in STEMI

The antiplatelet drugs prasugrel and ticagrelor had similar safety and efficacy among patients with acute myocardial infarction and ST segment elevations (STEMI), according to results of PRAGUE-18, the first randomised, head-to-head ...

Cardiology

Shorter dual antiplatelet duration holds up in NIPPON

A short-term course of dual antiplatelet therapy (DAPT) is non-inferior to a longer course in patients who have undergone placement of a particular kind of drug-eluting stent (DES), researchers reported here.

Cardiology

Patient-level model predicts in-hospital mortality in acute MI

(HealthDay)—A parsimonious patient-level clinical risk model can predict in-hospital mortality for patients with acute myocardial infarction, according to a study published in the Aug. 9 issue of the Journal of the American ...

page 18 from 36